select trial glp 1 semaglutide results Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design SELECT Cardiovascular Trial Information Clinical efficacy results from clinical

A phase 3, double-blind, randomized, placebo-controlled trial was conducted across seven countries

Pharmacokinetic parameters, time to reach the maximum concentration (T max ), clearance rectified by bioavailability (CL z/F ), mean resident time (MRT), including area under the plasma concentration-time curve (AUC), elimination half-life (T 1/2 ), apparent volume of distribution rectified by bioavailability (V z/F ) were analyzed by a non-compartmental method using Winnonlin 8.10 software (Pharsight Co., United States) software

Custom Software Development Agile Development Process AI & Automation Solutions Shopify & E-commerce Our technology startup agency is powered by a team of highly skilled developers, engineers, and tech innovators dedicated Our highly skilled development and engineering team brings innovation and technical expertise to every project

READY TO TAKE THE NEXT STEP

Setting up your account for Sign to affirm: